Filing Details
- Accession Number:
- 0000899243-18-029386
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-19 20:12:27
- Reporting Period:
- 2018-11-19
- Accepted Time:
- 2018-11-19 20:12:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1631650 | Aimmune Therapeutics Inc. | AIMT | Pharmaceutical Preparations (2834) | 452748244 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1650322 | Alexander Donald Jayson Dallas | Aimmune Therapeutics, Inc. 8000 Marina Boulevard, Suite 300 Brisbane CA 94005-1884 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.0001 Par Value | Acquisiton | 2018-11-19 | 3,600 | $27.56 | 63,600 | No | 4 | P | Direct | |
Common Stock, $0.0001 Par Value | Acquisiton | 2018-11-19 | 50 | $27.56 | 63,650 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |